Enhanced antitumor effect of shikonin by inhibiting Endoplasmic Reticulum Stress via JNK/c-Jun pathway in human glioblastoma stem cells

Biochemical and Biophysical Research Communications
Jing LiuYunhui Liu

Abstract

Though previous study demonstrated that shikonin could exert its antitumor activity by inducing apoptosis and necrosis, the pro-survival mechanisms involved in its antitumor process are still little to know. In the present study, for the first time, we found a protective mechanism was simultaneously activated which caused the reduced sensitivity of glioblastoma stem cells (GSCs) to the cytotoxicity of shikonin. Reduced active caspase-9 expression and enhanced mitochondrial membrane potential (MMP) were intriguingly observed within 24 h treatment by shikonin in GSCs. Further investigation identified that Endoplasmic Reticulum Stress (ERS) was involved in its antitumor process, which compromised the cytotoxicity of shikonin toward GSCs. Inhibiting ERS by 4-phenylbutyric acid (4-PBA) markedly enhanced the cytotoxicity of shikonin in GSCs. The consistent result was simultaneously observed in the GSCs-xenografted mice. Furthermore, our results identified that JNK/c-Jun pathway was involved in the antitumor process of shikonin, providing a mechanism by which ERS reduced the cytotoxicity of shikonin toward GSCs. Altogether, the novel observation in the present study identified that inhibiting ERS would be an attractive new approach to...Continue Reading

References

Nov 26, 1996·Proceedings of the National Academy of Sciences of the United States of America·E D WernerA A McCracken
Jan 5, 2000·The Journal of Biological Chemistry·S KharbandaD Kufe
Jul 27, 2002·Annual Review of Cell and Developmental Biology·Heather P HardingDavid Ron
Nov 25, 2003·Oncogene·David G BreckenridgeGordon C Shore
Feb 7, 2004·Cell Death and Differentiation·R V RaoD E Bredesen
Apr 8, 2004·Developmental Cell·Beth Levine, Daniel J Klionsky
Jul 1, 2004·Journal of Asian Natural Products Research·Zhen WuTakashi Ikejima
Jan 11, 2005·The Journal of Pathology·D B Longley, P G Johnston
Apr 29, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·Vincent TongFrank S Abbott
Oct 13, 2006·Molecular and Cellular Biology·Maiko OgataKazunori Imaizumi
May 22, 2007·Molecular Cancer Therapeutics·Weidong HanXun Hu
Nov 22, 2007·Cardiovascular Research·Thomas G NührenbergDietlind Zohlnhöfer
Jun 24, 2008·Molecular Cell·Yongjie WeiBeth Levine
Jan 24, 2009·International Journal of Cancer. Journal International Du Cancer·Huanjie YangJinbao Liu
Oct 2, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Chibo LiuJiayu Chen

❮ Previous
Next ❯

Citations

Nov 7, 2015·Biochemical and Biophysical Research Communications·Jing LiuYun-Hui Liu
Sep 25, 2012·Experimental Cell Research·Alexander BirbrairOsvaldo Delbono
Jun 16, 2016·Oncotarget·Yanzhou YangWai Yee Chan
Aug 8, 2019·Cancer Cell International·Carolina Escardó PereyraFloriano Paes Silva-Jr
Jul 1, 2020·Arhiv za higijenu rada i toksikologiju·Bensu KarahalilSultan Nacak Baytas

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis